An HSV-1 gD mutant virus as an entry-impaired live virus vaccine
Authors:
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Preventing Varicella-Zoster DiseaseClinical Microbiology Reviews, 2005
- Mutations in the N Termini of Herpes Simplex Virus Type 1 and 2 gDs Alter Functional Interactions with the Entry/Fusion Receptors HVEM, Nectin-2, and 3- O -Sulfated Heparan Sulfate but Not with Nectin-1Journal of Virology, 2003
- Function of Herpes Simplex Virus Type 1 gD Mutants with Different Receptor-Binding Affinities in Virus Entry and FusionJournal of Virology, 2003
- Structure-Based Mutagenesis of Herpes Simplex Virus Glycoprotein D Defines Three Critical Regions at the gD-HveA/HVEM Binding InterfaceJournal of Virology, 2003
- Structure-Based Analysis of the Herpes Simplex Virus Glycoprotein D Binding Site Present on Herpesvirus Entry Mediator HveA (HVEM)Journal of Virology, 2002
- Herpes Simplex Virus Glycoprotein D Bound to the Human Receptor HveAMolecular Cell, 2001
- Development of a Syngenic Murine B16 Cell Line-Derived Melanoma Susceptible to Destruction by Neuroattenuated HSV-1Molecular Therapy, 2001
- Localization of the gD-Binding Region of the Human Herpes Simplex Virus Receptor, HveAJournal of Virology, 2001
- Herpes Simplex Esophagitis in Patients with AIDS: Report of 34 CasesClinical Infectious Diseases, 1996
- Herpes Simplex Virus Infections of the Central Nervous System: Therapeutic and Diagnostic ConsiderationsClinical Infectious Diseases, 1995